Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Plos One|June 6, 2020
An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesisDaniel J García-Domínguez, Lourdes Hontecillas-Prieto, Eduardo Andrés León, et al.Cancers|November 11, 2022
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic StrategiesSara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet, et al.International Journal of Molecular Sciences|March 29, 2023
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor CellsMaría Luisa Sánchez-León, Carlos Jiménez-Cortegana, Silvia Silva Romeiro, et al.Neuromolecular Medicine|February 28, 2025
Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative ReviewJuan Antonio Flores-Cordero, Amalia Aranaz-Murillo, Teresa Vilariño-García, et al.International Journal of Molecular Sciences|January 23, 2024
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight CancerDaniel J García-Domínguez, Soledad López-Enríquez, Gonzalo Alba, et al.Oncotarget|August 25, 2018
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcomaDaniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Rodríguez-Núñez, et al.Neurobiology of Aging|November 4, 2011
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretasesJuan Ignacio Diaz-Hernandez, Rosa Gomez-Villafuertes, Miriam León-Otegui, et al.Cytokine & Growth Factor Reviews|June 27, 2025
Leptin as a mechanistic link between obesity and systemic lupus erythematousDaniel J García-Domínguez, Lourdes Hontecillas-Prieto, Laura Lucenilla-Barrenechea, et al.Immunobiology|March 28, 2025
Decreased number of myeloid-derived suppressor cells in the placental trophoblast of gestational diabetes mellitus. Possible role of leptinMalika Tami, Lourdes Hontecillas-Prieto, Daniel García-Domínguez, et al.International Journal of Cancer|March 28, 2018
EphA2 receptor is a key player in the metastatic onset of Ewing sarcomaSilvia Garcia-Monclús, Roser López-Alemany, Olga Almacellas-Rabaiget, et al.Pageof 4